Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relapse of colchicine-intolerant, corticosteroid-dependent recurrent idiopathic pericarditis after perigestational discontinuation of anakinra: uncertain safety of anakinra in pregnancy and the need for shared decision-making.

BMJ case reports·2023
Same author

Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA) in a Patient Taking Lisdexamfetamine.

South Dakota medicine : the journal of the South Dakota State Medical Association·2022
Same author

CYP2C19 genotype-directed P<sub>2</sub>Y<sub>12</sub> inhibitor antiplatelet therapy normalizes risk for major adverse cardiovascular events after percutaneous coronary intervention.

Indian heart journal·2021
Same author

Robotic-Assisted Percutaneous Coronary Intervention Through Transradial Approach: Experience in 4 Patients with Complex Lesions.

Texas Heart Institute journal·2020
Same author

Triple-Guidewire Technique for Treating Stent Underexpansion in Severely Calcified Coronary Artery Lesions.

Texas Heart Institute journal·2020
Same author

Orbital Atherectomy and Heavily Calcified Saphenous Vein Graft Intervention.

Texas Heart Institute journal·2020
Same journal

2025 Scholars' Research Symposium Abstract: Influence of Disability Education, Panel Discussion on Comfort and Knowledge of Healthcare Providers in South Dakota.

South Dakota medicine : the journal of the South Dakota State Medical Association·2025
Same journal

2025 Scholars' Research Symposium Abstract: Improving Interactions During Medical Interpretation: An Educational Module for Medical Students.

South Dakota medicine : the journal of the South Dakota State Medical Association·2025
Same journal

2025 Scholars' Research Symposium Abstract: Walk With Ease Benefiting South Dakota.

South Dakota medicine : the journal of the South Dakota State Medical Association·2025
Same journal

2025 Scholars' Research Symposium Abstract: Ultrasonographic Accuracy in Rural vs Urban Counties.

South Dakota medicine : the journal of the South Dakota State Medical Association·2025
Same journal

2025 Scholars' Research Symposium Abstract: Minimizing Grief and Loss Through Advanced Care Planning.

South Dakota medicine : the journal of the South Dakota State Medical Association·2025
Same journal

2025 Scholars' Research Symposium Abstract: Food Security During Pregnancy and Adverse Birth Outcomes.

South Dakota medicine : the journal of the South Dakota State Medical Association·2025
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K

Implementing the 2013 cholesterol management guidelines into clinical practice.

Shawn C Kelly, Shenjing Li, Marian Petrasko

    South Dakota Medicine : the Journal of the South Dakota State Medical Association
    |May 20, 2015
    PubMed
    Summary
    This summary is machine-generated.

    New guidelines shift cholesterol management focus from LDL targets to potent statin therapy for high-risk patients. Utilize the ASCVD pooled cohort calculator to identify individuals needing intensive treatment for atherosclerotic cardiovascular disease prevention.

    More Related Videos

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    15.0K
    Cholesterol Efflux Assay
    07:54

    Cholesterol Efflux Assay

    Published on: March 6, 2012

    30.6K

    Related Experiment Videos

    Last Updated: Jan 13, 2026

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
    10:28

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

    Published on: March 15, 2022

    5.7K
    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    15.0K
    Cholesterol Efflux Assay
    07:54

    Cholesterol Efflux Assay

    Published on: March 6, 2012

    30.6K

    Area of Science:

    • Cardiology
    • Public Health
    • Clinical Practice Guidelines

    Background:

    • Cholesterol management aims to reduce atherosclerotic cardiovascular disease (ASCVD) events.
    • Recent guidelines signal a shift in managing high-risk patients.

    Purpose of the Study:

    • To outline the updated approach to cholesterol management in high-risk patients.
    • To guide clinicians in implementing current American Heart Association (AHA)/American College of Cardiology (ACC) guidelines.

    Main Methods:

    • The article reviews the revised recommendations for statin therapy.
    • It introduces the ASCVD pooled cohort calculator as a risk assessment tool.

    Main Results:

    • The focus is now on potent statin therapy for highest ASCVD risk, not specific low-density lipoprotein (LDL) targets.
    • Statin therapy cessation and routine adverse event monitoring are re-evaluated.

    Conclusions:

    • Clinicians should adopt a risk-based strategy using the ASCVD calculator.
    • Prioritize potent statin therapy for individuals identified as high-risk for ASCVD events.